Drug-induced hyperkalemia: old culprits and new offenders.
about
Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.Aldosterone receptor antagonists: effective but often forgotten.Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.Danger of salt substitutes that contain potassium in patients with renal failure.Patient-reported and actionable safety events in CKD.Extracellular potassium homeostasis: insights from hypokalemic periodic paralysis.Pathogenesis, diagnosis and management of hyperkalemiaBeta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control studyHyperkalemia: a review.Advances in treatment of hyperkalemia in chronic kidney disease.Chronic administration of oral trimethoprim-sulfamethoxazole for acne vulgaris.Severe hyperkalaemia: demographics and outcomeProspective observational evaluation of incidences and implications of drug-drug interactions induced adverse drug reactions in critically ill patients.Life-threatening hyperkalemia in a patient with normal renal functionCan dual blockade of the renin-angiotensin system reduce progression of kidney disease beyond monotherapy?Acid-base and electrolyte abnormalities observed in patients receiving cardiovascular drugs.Impact of hyperkalaemia definition on incidence assessment: implications for epidemiological research based on a large cohort study in newly diagnosed heart failure patients in primary care.Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.Potential side effects of renin inhibitors--mechanisms based on comparison with other renin-angiotensin blockers.Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.Long-term continuous administration of a hydro-ethanolic extract of Synedrella nodiflora (L) Gaertn in male Sprague-Dawley rats: biochemical, haematological and histopathological changes.Managing cardiovascular and renal risk: the potential of direct renin inhibition.Renal adverse effects of nonsteroidal anti-inflammatory drugs.Airway drug pharmacokinetics via analysis of exhaled breath condensate.Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy.Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review.What is the risk of hyperkalaemia in heart failure?Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant Staphylococcus aureus and other infections: nature or nurture?Drug-induced hyperkalemia.Physiology and pathophysiology of potassium homeostasis.Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia.Incidence of and risk factors for newly diagnosed hyperkalemia after hospital discharge in non-dialysis-dependent CKD patients treated with RAS inhibitors.Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction.NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia.Potassium abnormalities in current clinical practice: frequency, causes, severity and management.Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet.Trimethoprim-induced hyperkalaemia -- lessons in data mining.Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism.
P2860
Q33156009-55990E56-2F8C-4209-94B1-8C356230104CQ33688485-96F955BE-128B-4964-96F9-68F7D4B9D6DBQ33701269-3A927F4C-1831-48EB-AB13-81D4E80A087BQ33813384-AB71C7F4-AE23-4E19-ABEC-29331FECFEF0Q33814930-C2539C68-1ED8-447C-9937-15BBB9A10760Q34039490-94E2043F-14C4-4C84-B273-AC14E1C88F31Q34156350-E57C77F5-9E43-48FC-BDFA-CA465DFEEB5BQ34281438-D646FAE0-8539-4A66-A97D-6492AA95000AQ34448823-321205BF-38A3-446F-8B6A-37BFA8B87790Q34491934-C4BC46DE-3230-4E33-80E9-8616812AFF1EQ35200084-404B2E02-5B84-427B-BBE6-90526D247936Q35227610-48FF6380-9ABD-43CA-A947-E0A97BA0DE9BQ35228977-A7734558-6E93-44AF-8AB3-372729389422Q35310875-31445C24-1EBD-483C-A6FD-7E610B715016Q35609741-792CF570-0E0C-4180-B328-D0F32C9883B4Q35636701-6B0C9858-6751-4B8F-BD85-A5F4EFBC268EQ36008616-3047EB77-701D-4CF3-823E-03B68AABCD70Q36126918-A041CEAC-8442-4BFE-A19A-5C4BF4267676Q36565036-FF351A61-D209-46DB-B458-C73D28CB678FQ36712216-2584DA75-73C9-463B-995C-AB41BBCF5A25Q37300313-B329FCAF-7F31-4FCB-BDC7-E489A11F3E13Q37510348-C4AE96E8-E497-4D79-AABE-0133FE8F0B8DQ37615395-A7A9212D-D97A-48EB-8E1F-44EC48B25219Q37625778-9C004EDB-6F4D-4B88-9467-759DC5A3AC9BQ37679929-B6DF49D8-4554-451F-ADF3-27A11B6EF7BBQ37722892-ABE88363-26E0-4CC2-8032-C12C3C2208A4Q37902667-407EEFA6-E6A0-48FC-86F8-0E2655CDFF2EQ37925006-8D18227B-2113-4F77-8CAB-44D7E0CA3FB3Q38071956-709A7DE1-C46D-4D3D-A01F-5467F6AF577BQ38232308-869EAC78-D936-4F05-A5A2-DECFEF6E3212Q38984717-7FA3C337-19B3-4F20-BE56-53271A0A5119Q38999653-3D7550CE-E34C-4B9C-981D-4E4309B818A0Q40055689-CDDF1F11-6333-4A3F-B18A-365D2AEA677BQ40810174-ED283849-11A6-423A-8F79-1BA3D9650EAEQ40920604-417A4DCD-2680-4666-96B4-A73DB79A1695Q41233248-597666F1-9709-4CA9-B2F1-C16C468565EEQ41833844-6BD7B1B6-FAD5-456A-A4D4-63623FC84F92Q42759628-83A8FE18-CECA-4D22-B0D7-16FFB400E9B6Q44756155-78BC9514-D7A5-4BCF-8D89-6CA1F82601D8Q46654323-03C50385-12E1-44AC-A984-577F708A0718
P2860
Drug-induced hyperkalemia: old culprits and new offenders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug-induced hyperkalemia: old culprits and new offenders.
@ast
Drug-induced hyperkalemia: old culprits and new offenders.
@en
Drug-induced hyperkalemia: old culprits and new offenders.
@nl
type
label
Drug-induced hyperkalemia: old culprits and new offenders.
@ast
Drug-induced hyperkalemia: old culprits and new offenders.
@en
Drug-induced hyperkalemia: old culprits and new offenders.
@nl
prefLabel
Drug-induced hyperkalemia: old culprits and new offenders.
@ast
Drug-induced hyperkalemia: old culprits and new offenders.
@en
Drug-induced hyperkalemia: old culprits and new offenders.
@nl
P1476
Drug-induced hyperkalemia: old culprits and new offenders.
@en
P2093
Perazella MA
P304
P356
10.1016/S0002-9343(00)00496-4
P407
P577
2000-09-01T00:00:00Z